Publications by authors named "Josh Yuan"

Claim this Profile
A
A Reduction in B, T, and Natural Killer Cells Expressing CD38 by TAK-079 Inhibits the Induction and Progression of Collagen-Induced Arthritis in Cynomolgus Monkeys.
Wouter Korver, Mary Carsillo, Josh Yuan, Neeraja Idamakanti, Matthew Wagoner

J Pharmacol Exp Ther· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development under the "Metabolites in Safety Testing" Regulatory Guidance.
Simone Schadt, Bojan Bister, Swapan K Chowdhury, Christoph Funk, Cornelis E C A Hop, Josh Yuan

Drug Metab Dispos· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of the cytolytic anti-CD38 human monoclonal antibody TAK-079 in monkey - model assisted preparation for the first in human trial.
Stefan Roepcke, Nele Plock, Josh Yuan, Eric R Fedyk, Gezim Lahu

Pharmacol Res Perspect· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and metabolism of a COX-2 inhibitor, valdecoxib, in mice.
Ji Y Zhang, Josh J Yuan, Yue-Fen Wang, Roy H Bible, Alan P Breau

Drug Metab Dispos· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disposition of a specific cyclooxygenase-2 inhibitor, valdecoxib, in human.
Josh J Yuan, Dai-Chang Yang, Ji Y Zhang, Roy Bible, Aziz Karim

Drug Metab Dispos· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis